BE463440A - - Google Patents
Info
- Publication number
- BE463440A BE463440A BE463440DA BE463440A BE 463440 A BE463440 A BE 463440A BE 463440D A BE463440D A BE 463440DA BE 463440 A BE463440 A BE 463440A
- Authority
- BE
- Belgium
- Prior art keywords
- liquid
- solution
- active
- alkali
- product
- Prior art date
Links
- 239000007788 liquid Substances 0.000 claims description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 239000000047 product Substances 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 15
- 239000003513 alkali Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- 239000003960 organic solvent Substances 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 239000007954 growth retardant Substances 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 238000000502 dialysis Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 210000001124 body fluid Anatomy 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 239000003966 growth inhibitor Substances 0.000 claims description 3
- CEQFOVLGLXCDCX-WUKNDPDISA-N methyl red Chemical compound C1=CC(N(C)C)=CC=C1\N=N\C1=CC=CC=C1C(O)=O CEQFOVLGLXCDCX-WUKNDPDISA-N 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 210000002700 urine Anatomy 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 239000010839 body fluid Substances 0.000 claims description 2
- 230000000979 retarding effect Effects 0.000 claims description 2
- 235000019441 ethanol Nutrition 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 229920000298 Cellophane Polymers 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE463440A true BE463440A (enrdf_load_stackoverflow) |
Family
ID=115550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE463440D BE463440A (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE463440A (enrdf_load_stackoverflow) |
-
0
- BE BE463440D patent/BE463440A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE463440A (enrdf_load_stackoverflow) | ||
| FR2635533A1 (fr) | Procede de fabrication du melange de ribonucleotides | |
| FR2519253A1 (fr) | Procede pour isoler des composes a effet laxatif du sene medicinal, ces composes et leurs utilisations therapeutiques | |
| WO2008061984A2 (fr) | Procede d'extraction d'aloine | |
| EP0207846A2 (fr) | Procédé pour la séparation et l'isolement du nosiheptide | |
| FR2641283A1 (fr) | Procede d'extraction de substances colorantes | |
| BE844998A (fr) | Procede pour isoler des agents actifs d'extraits vegetaux | |
| CH173727A (fr) | Procédé de purification de l'acide phosphorique. | |
| BE707409A (enrdf_load_stackoverflow) | ||
| CN114315860A (zh) | 一种西罗莫司粗品的制备方法 | |
| CH332662A (fr) | Procédé de préparation d'émétine | |
| CH123817A (fr) | Procédé d'obtention de préparations concentrées de vitamine C. | |
| CH335063A (fr) | Procédé pour l'obtention d'hécogénine | |
| CN114656355A (zh) | 一种从发酵液中提取丙酮酸的方法 | |
| BE532575A (enrdf_load_stackoverflow) | ||
| CH294890A (fr) | Procédé pour la purification de la pénicilline. | |
| BE526416A (enrdf_load_stackoverflow) | ||
| BE348223A (enrdf_load_stackoverflow) | ||
| BE425391A (enrdf_load_stackoverflow) | ||
| CH337541A (fr) | Procédé pour séparer en deux fractions des alcaloïdes de plantes Rauwolfia | |
| CH106039A (fr) | Procédé pour transférer la vitamine soluble dans les corps gras (vitamine A), de la matière grasse qui la contient à ses solvants organiques. | |
| BE505856A (enrdf_load_stackoverflow) | ||
| CH414945A (fr) | Procédé d'obtention de galantamine pure à partir de plantes de la famille des " Amaryllidaceae " | |
| BE531071A (enrdf_load_stackoverflow) | ||
| CH309457A (fr) | Procédé de préparation du chlorhydrate de chlortétracycline. |